Revelation Biosciences, Inc. financial statements
Revelation Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 8.91M | 10-K |
| Cash and equivalents | USD 10.7M | 10-Q |
| Total debt | USD 746.78K | EODHD |
Revelation Biosciences, Inc. financials on 6ix · Revelation Biosciences, Inc. on 6ix